116 related articles for article (PubMed ID: 1099729)
1. The treatment of rejection. A trial of acetylsalicylic acid, dipyridamole, and heparin.
George CR; Slichter SJ; Quadracci LJ; Kenny GM; Dennis MB; Striker GE; Harker LA
Transplantation; 1975 Sep; 20(3):237-40. PubMed ID: 1099729
[TBL] [Abstract][Full Text] [Related]
2. [Pulmonary pressure-flow relationship following pulmonary microembolism: preventive therapy with heparin and acetylsalicylic acid/dipyridamole].
Leinberger H; Bleyl U; Brückner UB; Klöss T; Metzker M; Saggau W; Schmier J
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1175-7. PubMed ID: 347773
[No Abstract] [Full Text] [Related]
3. Are agents affecting platelet functions clinically useful?
Verstraete M
Am J Med; 1976 Dec; 61(6):897-914. PubMed ID: 795299
[TBL] [Abstract][Full Text] [Related]
4. A controlled trial of dipyridamole in human renal transplantation and an assessment of platelet function studies in rejection.
Anderson M; Dewar P; Fleming LB; Hacking PM; Morley AR; Murray S; Swinney J; Taylor RM; Uldall PR; Wardle EN
Clin Nephrol; 1974; 2(3):93-9. PubMed ID: 4603996
[No Abstract] [Full Text] [Related]
5. Preliminary report: treatment of the hemolytic-uremic syndrome with aspirin and dipyridamole.
Arenson EB; August CS
J Pediatr; 1975 Jun; 86(6):957-61. PubMed ID: 1127537
[TBL] [Abstract][Full Text] [Related]
6. Controlled trial of platelet anti-aggregating agents and subcutaneous heparin in prevention of postoperative deep vein thrombosis in high risk patients.
Dechavanne M; Ville D; Viala JJ; Kher A; Faivre J; Pousset MB; Dejour H
Haemostasis; 1975; 4(2):94-100. PubMed ID: 1205340
[TBL] [Abstract][Full Text] [Related]
7. Thrombotic thrombocytopenic purpura. Three cases with platelet and fibrinogen survival studies.
Berberich FR; Cuene SA; Chard RL; Hartmann JR
J Pediatr; 1974 Apr; 84(4):503-9. PubMed ID: 4858082
[No Abstract] [Full Text] [Related]
8. Effect of heparin, dextran and dipyridamole on the immunogenicity of renal allografts.
Callender CO; Toledo-Pereyra LH; Simmons RL; Najarian JS
Surg Forum; 1974; 25(0):277-9. PubMed ID: 4155132
[No Abstract] [Full Text] [Related]
9. Prevention of kidney arteriosclerosis: heparin, dipyridamole, warfarin, and plasma exchange.
Kincaid-Smith P
Transplant Proc; 1987 Aug; 19(4 Suppl 5):82-4. PubMed ID: 3303574
[No Abstract] [Full Text] [Related]
10. Platelet inhibitors in human renal homotransplantation: randomized comparison of aspirin versus dipyridamole.
Kauffman HM; Adams MB; Hebert LA; Walczak PM
Transplant Proc; 1980 Jun; 12(2):311-4. PubMed ID: 6771905
[No Abstract] [Full Text] [Related]
11. A kinetic evaluation of hemostasis in renal disease.
George CR; Slichter SJ; Quadracci LJ; Striker GE; Harker LA
N Engl J Med; 1974 Nov; 291(21):1111-5. PubMed ID: 4608640
[No Abstract] [Full Text] [Related]
12. Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting.
Edmondson RA; Cohen AT; Das SK; Wagner MB; Kakkar VV
Lancet; 1994 Oct; 344(8927):914-8. PubMed ID: 7934346
[TBL] [Abstract][Full Text] [Related]
13. The effect of combined aspirin and dipyridamole therapy on thrombus formation in an arterial thrombogenic lesion in the dog.
Deen HG; Sundt TM
Stroke; 1982; 13(2):179-84. PubMed ID: 7064188
[TBL] [Abstract][Full Text] [Related]
14. Hyperacute renal allograft rejection in the primate. Intrarenal effects of heparin and associated net release of factor VIII activity and kallikrein activation.
Busch GJ; Kobayashi K; Hollenberg NK; Birtch AG; Colman RW
Am J Pathol; 1975 Jul; 80(1):1-20. PubMed ID: 1098475
[TBL] [Abstract][Full Text] [Related]
15. Controlled, double-blind trial of antiplatelet aggregating agents in vascular renal allograft rejection.
Mathew TH; Hogan GP; Lewers DT; Bauer H; Maher JF; Schreiner GE
Transplant Proc; 1971 Mar; 3(1):901-4. PubMed ID: 4937989
[No Abstract] [Full Text] [Related]
16. Modification of the vascular lesions of rejection in cadaveric renal allografts by dipyridamole and anticoagulants.
Kincaid-Smith P
Lancet; 1969 Nov; 2(7627):920-2. PubMed ID: 4186594
[No Abstract] [Full Text] [Related]
17. Inhibition of experimental arterial thrombosis in dogs with platelet-deaggregating agents.
Danese CA; Haimov M
Surgery; 1971 Dec; 70(6):927-34. PubMed ID: 5124672
[No Abstract] [Full Text] [Related]
18. Nature of hyperacute (accelerated second set) rejection in dog renal allografts and effects of heparin on rejection process.
Amery AH; Pegrum GD; Risdon RA; Williams G
Br Med J; 1973 Feb; 1(5851):455-8. PubMed ID: 4570252
[TBL] [Abstract][Full Text] [Related]
19. Platelet alterations during accelerated rejection of canine renal allografts.
Claes G; Ljungqvist U
Acta Chir Scand; 1973; 139(2):123-6. PubMed ID: 4577926
[No Abstract] [Full Text] [Related]
20. Dipyridamole ("Persantin") and aspirin and the prevention of post-operative deep-vein thrombosis.
Renney JT; O'Sullivan EF
Thromb Diath Haemorrh Suppl; 1973; 55():267-71. PubMed ID: 4804075
[No Abstract] [Full Text] [Related]
[Next] [New Search]
